Diabetes Mellitus Clinical Trial
Official title:
Evaluation of Diabetes Mellitus and Smoking on Periodontitis Classifications Using the 1999 and 2018 Periodontal Disease Classifications: a Retrospective Study
Verified date | March 2021 |
Source | Okan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of present study was to evaluate how the 2018 classification reflects the severity, extent and progression of the disease, taking into account the risk factors for periodontal disease, smoking and diabetes, when compared with the 1999 classification.
Status | Completed |
Enrollment | 202 |
Est. completion date | March 1, 2021 |
Est. primary completion date | January 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with a complete periodontal chart and full mouth radiographic series at baseline - Diabetes Mellitus:Patients who consulted by an internist/endocrinologist and underwent HbA1c measurements in the last three months. - Smoking status:All current smokers who had smoked more than 100 cigarettes in their lifetimes and used cigarettes for more than five years - Patients meeting the case definition of periodontitis - Relative radiographic bone loss(in %) was assessed on peri-apical radiograph films Exclusion Criteria: - individuals with a systemic disease other than diabetes - Smokers not reporting the number of cigarette/days or patient(s) with diabetes that do not report Hemoglobin A1c (HbA1c) test results for diabetes. - individuals who do not suffer from periodontitis - Patients with inaccessible files because of bad debt, destroyed record, or deceased. |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul Okan University | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Okan University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The advantages of including the effect of diabetes and smoking on periodontal disease in the 2018 classification compared to the 1999 classification | In our study, both classifications reflected the severity of periodontal disease differently. The 2018 classification outperformed the 1999 classification for staging and grading of periodontitis severity and progression. Consideration of the risk factors listed in the 2018 classification has been useful approach for correct diagnosis, evidence-based clinical decisions, prognosis of treatment, and periodontal disease prevention. The 2018 periodontal disease classification is more detailed and comprehensive than the 1999 classification, and this classification is thought to revise the criticisms of the 1999 classification. | The present retrospective study included individuals who were examined and had periodontal measurements made and recorded at the Istanbul Okan University Periodontology Department between 09/01/2018 and 12/01/2019. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |